Polymeric lamellar substrate particles as carrier adjuvant for recombinant hepatitis B surface antigen vaccine

Vaccine

Volumn 27, Issue 17, 2009, Pages 2372-2378

  Saini, Vinay ^a   Sahoo, M K ^b   Murthy, P K ^b   Kohli, Dharmveer ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Hepatitis B surface antigen; IFN ; IgG; Lymphoproliferation; NO; PLSP

Indexed keywords

ALUMINUM DERIVATIVE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; NANOCARRIER; NITRIC OXIDE; POLYLACTIDE; POLYMERIC LAMELLAR SUBSTRATE PARTICLE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PARTICLE SIZE; PARTICULATE MATTER; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; DRUG ADMINISTRATION SCHEDULE; DRUG CARRIERS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MACROPHAGES, PERITONEAL; MICE; MICROSPHERES; NITRIC OXIDE; POLYMERS; VACCINES, SYNTHETIC;

EID: 62249108660     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.02.023     Document Type: Article

References (44)

1. Saraf S., Mishra D., Asthana A., Jain R., Singh S., and Jain N.K. Lipid microparticles for mucosal immunization against hepatitis B. Vaccine 24 1 (2006) 45-56
2. Jaganathan K.S., and Vyas S.P. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine 24 19 (2006) 4201-4211
3. Feng L., Qi X.R., Zhou X.J., Maitani Y., Wang S.C., Jiang Y., et al. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres. J Control Release 112 1 (2006) 35-42
4. Vyas S.P., Singh R.P., Jain S., Mishra V., Mahor S., Singh P., et al. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int J Pharm 296 1-2 (2005) 80-86
5. Xu D.Z., Huang K.L., Zhao K., Xu L.F., Shi N., Yuan Z.H., et al. Vaccination with recombinant HBsAg-HBIG complex in healthy adults. Vaccine 23 20 (2005) 2658-2664
6. Hilleman M.R. Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. Vaccine 21 32 (2003) 4626-4649
7. Shi L., Caulfield M.J., Chern R.T., Wilson R.A., Sanyal G., and Volkin D.B. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. J Pharm Sci 91 4 (2002) 1019-1035
8. Singh M., Li X.M., McGee J.P., Zamb T., Koff W., Wang C.Y., et al. Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice. Vaccine 15 5 (1997) 475-481
9. Lima K.M., and Rodrigues Junior J.M. Poly-dl-lactide-co-glycolide microspheres as a controlled release antigen delivery system. Braz J Med Biol Res 32 2 (1999) 171-180
10. Men Y., Tamber H., Audran R., Gander B., and Corradin G. Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres. Vaccine 15 12-13 (1997) 1405-1412
11. Tacket C.O., Roy M.J., Widera G., Swain W.F., Broome S., and Edelman R. Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. Vaccine 17 22 (1999) 2826-2829
12. Roberts L.K., Barr L.J., Fuller D.H., McMahon C.W., Leese P.T., and Jones S. Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device. Vaccine 23 40 (2005) 4867-4878
13. Partidos C.D., Vohra P., Jones D., Farrar G., and Steward M.W. CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles. J Immunol Methods 206 1-2 (1997) 143-151
14. Bos G.W., Kanellos T., Crommelin D.J., Hennink W.E., and Howard C.R. Cationic polymers that enhance the performance of HbsAg DNA in vivo. Vaccine 23 4 (2004) 460-469
15. Venkataprasad N., Coombes A.G., Singh M., Rohde M., Wilkinson K., Hudecz F., et al. Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers. Vaccine 17 15-16 (1999) 1814-1819
16. Absolom D.R., Zingg W., and Neumann A.W. Protein adsorption to polymer particles: role of surface properties. J Biomed Mater Res 21 2 (1987) 161-171
17. Moynihan J.S., Blair J., Coombes A., D'Mello F., and Howard C.R. Enhanced immunogenicity of a hepatitis B virus peptide vaccine using oligosaccharide ester derivative microparticles. Vaccine 20 13-14 (2002) 1870-1876
18. Coombes A.G., Lavelle E.C., Jenkins P.G., and Davis S.S. Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen. Vaccine 14 15 (1996) 1429-1438
19. Singh M., Li X.M., Wang H., McGee J.P., Zamb T., Koff W., et al. Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine. Infect Immun 65 5 (1997) 1716-1721
20. Singh M., Li X.M., Wang H., McGee J.P., Zamb T., Koff W., et al. Controlled release microparticles as a single dose diphtheria toxoid vaccine: immunogenicity in small animal models. Vaccine 16 4 (1998) 346-352
21. Thanavala Y. Novel approaches to vaccine development against HBV. J Biotechnol 44 1-3 (1996) 67-73
22. Johansen P., Moon L., Tamber H., Merkle H.P., Gander B., and Sesardic D. Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs. Vaccine 18 3-4 (1999) 209-215
23. Lavelle E.C., Yeh M.K., Coombes A.G., and Davis S.S. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Vaccine 17 6 (1999) 512-529
24. Schirmbeck R., Deml L., Melber K., Wolf H., Wagner R., and Reimann J. Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens. Vaccine 13 9 (1995) 857-865
25. Ghaffari A., Miller C.C., McMullin B., and Ghahary A. Potential application of gaseous nitric oxide as a topical antimicrobial agent. Nitric Oxide 14 1 (2006) 21-29
26. Coombes A.G., Major D., Wood J.M., Hockley D.J., Minor P.D., and Davis S.S. Resorbable lamellar particles of polylactide as adjuvants for influenza virus vaccines. Biomaterials 19 11-12 (1998) 1073-1081
27. Coombes A.G., Lavelle E.C., and Davis S.S. Biodegradable lamellar particles of poly(lactide) induce sustained immune responses to a single dose of adsorbed protein. Vaccine 17 19 (1999) 2410-2422
28. Jabbal-Gill I., Lin W., Jenkins P., Watts P., Jimenez M., Illum L., et al. Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines. Vaccine 18 3-4 (1999) 238-250
29. Jabbal-Gill I., Lin W., Kistner O., Davis S.S., and Illum L. Polymeric lamellar substrate particles for intranasal vaccination. Adv Drug Deliv Rev 51 1-3 (2001) 97-111
30. Stivaktakis N., Nikou K., Panagi Z., Beletsi A., Leondiadis L., and Avgoustakis K. Immune responses in mice of beta-galactosidase adsorbed or encapsulated in poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres. J Biomed Mater Res A 73 3 (2005) 332-338
31. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 5259 (1970) 680-685
32. Jaganathan K.S., Singh P., Prabakaran D., Mishra V., and Vyas S.P. Development of a single-dose stabilized poly(d,l-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B. J Pharm Pharmacol 56 10 (2004) 1243-1250
33. Dixit S., Gaur R.L., Sahoo M.K., Joseph S.K., Murthy P.S., and Murthy P.K. Protection against L3 induced Brugia malayi infection in Mastomys coucha pre-immunized with BmAFII fraction of the filarial adult worm. Vaccine 24 31-32 (2006) 5824-5831
34. Elias F., Flo J., Rodriguez J.M., De Nichilo A., Lopez R.A., Zorzopulos J., et al. PyNTTTTGT prototype oligonucleotide IMT504 is a potent adjuvant for the recombinant hepatitis B vaccine that enhances the Th1 response. Vaccine 23 27 (2005) 3597-3603
35. Vordermeier H.M., Coombes A.G., Jenkins P., McGee J.P., O'Hagan D.T., Davis S.S., et al. Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles. Vaccine 13 16 (1995) 1576-1582
36. Matlaga B.F., Yasenchak L.P., and Salthouse T.N. Tissue response to implanted polymers: the significance of sample shape. J Biomed Mater Res 10 3 (1976) 391-397
37. Visscher G.E., Pearson J.E., Fong J.W., Argentieri G.J., Robison R.L., and Maulding H.V. Effect of particle size on the in vitro and in vivo degradation rates of poly(dl-lactide-co-glycolide) microcapsules. J Biomed Mater Res 22 8 (1988) 733-746
38. Mishra D., Dubey V., Asthana A., Saraf D.K., and Jain N.K. Elastic liposomes mediated transcutaneous immunization against Hepatitis B. Vaccine 24 22 (2006) 4847-4855
39. Rafati H., Lavelle E.C., Coombes A.G., Stolnik S., Holland J., and Davis S.S. The immune response to a model antigen associated with PLG microparticles prepared using different surfactants. Vaccine 15 17-18 (1997) 1888-1897
40. Babbitt B.P., Allen P.M., Matsueda G., Haber E., and Unanue E.R. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature 317 6035 (1985) 359-361
41. Babbitt B.P., Matsueda G., Haber E., Unanue E.R., and Allen P.M. Antigenic competition at the level of peptide-Ia binding. Proc Natl Acad Sci USA 83 12 (1986) 4509-4513
42. Rehermann B., and Chisari F.V. Hepatitis B virus: molecular biology and immunopathology-experimental and clinical features. In: Willson R.A. (Ed). Viral hepatitis: diagnosis, treatment, prevention (1997), Marcel Dekker, New York 91-108
43. Guidotti L.G., McClary H., Loudis J.M., and Chisari F.V. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J Exp Med 191 7 (2000) 1247-1252
44. Allen J.E., and Loke P. Divergent roles for macrophages in lymphatic filariasis. Parasite Immunol 23 7 (2001) 345-352